Skip to content

SUCAMPO PHARMACEUTICALS, INC.

CIK 0001365216

← back to feed
Revenue (TTM)
$235.32M
+26.2% YoY Q3 Oct 2017
Net Income (TTM)
−$158.08M
+88.9% YoY Q3 Oct 2017
EPS Diluted (TTM)
$0.46
+78.9% YoY Q3 Oct 2017
Gross Margin
23.9%
Q3 Oct 2017
Operating Margin
-55.5%
Q3 Oct 2017
Net Margin
-67.2%
Q3 Oct 2017
Free Cash Flow (TTM)
$25.98M
Q3 Oct 2017
Cash
$75.04M
Q3 Oct 2017
Total Debt
—
Q3 Oct 2017
Shares Outstanding
46.64M sh
Q3 Oct 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings